Vascular Therapies closes $17.3m financing

Bayer and Exscientia partner to bring AI to drug discovery

Verily Study Watch

FDA clears Verily Study Watch for additional capabilities


GHO Capital acquires Ardena

Johnson & Johnson

Johnson & Johnson misses the mark on Q4 revenue

Elemica branches out to pharma industry

Redesign Science to use OpenEye Scientific software for drug development

Dyve Biosciences hires new chief scientific officer

Dicerna and Novo Nordisk to develop RNAi therapies for liver-related cardio-metabolic diseases